Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amniotic fluid platelet factor 4 and beta-thromboglobulin

A A Saleh1, T Ozawa, M P Dombrowski

  • 1Department of Obstetrics and Gynecology, Hutzel Hospital, Wayne State University, Detroit, Mich.

Fetal Diagnosis and Therapy
|May 1, 1993
PubMed
Summary

Platelet activating factor (PAF) may influence fetal development. This study found higher levels of beta-thromboglobulin (BTG) and platelet factor 4 (PF4) in amniotic fluid from genetic amniocentesis compared to lung maturity samples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cancelable ear recognition system via optimized deep feature fusion.

Scientific reports·2026
Same author

Cervical lymph node TB: diagnostic yield and patient profile.

IJTLD open·2026
Same author

Optimal planning of integrated nuclear-hybrid renewable energy systems for electrical distribution networks based on artificial intelligence.

Scientific reports·2025
Same author

Impact of resveratrol and zinc on biomarkers of oxidative stress induced by <i>Trichinella spiralis</i> infection.

Journal of helminthology·2023
Same author

Acetazolamide loaded-silver nanoparticles: A potential treatment for murine trichinellosis.

Journal of helminthology·2023
Same author

Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy.

British journal of biomedical science·2022

Area of Science:

  • Reproductive Biology
  • Fetal Development
  • Hematology

Background:

  • Platelet activating factor (PAF) is a potent platelet activator found in human embryos and fetuses.
  • PAF is hypothesized to play a role in fetal lung maturation.
  • The impact of PAF on fetal platelet activation, indicated by beta-thromboglobulin (BTG) and platelet factor 4 (PF4) release, remains uninvestigated.

Purpose of the Study:

  • To investigate the levels of beta-thromboglobulin (BTG) and platelet factor 4 (PF4) in amniotic fluid.
  • To explore the potential relationship between BTG, PF4, and fetal lung maturation.
  • To determine the origin of BTG and PF4 in the amniotic fluid.

Main Methods:

  • Measurement of BTG and PF4 concentrations in amniotic fluid samples.

Related Experiment Videos

  • Samples were obtained from 78 genetic amniocenteses and 35 pulmonary maturity amniocenteses.
  • Correlation analysis with pulmonary maturity parameters: lecithin to sphingomyelin ratio and phosphatidylglycerol concentration.

    • Main Results:

    • BTG and PF4 levels were significantly higher in genetic amniocentesis samples compared to lung maturity samples (p < 0.001).
    • No correlation was found between BTG, PF4 levels and established pulmonary maturity parameters.
    • Findings suggest that BTG and PF4 originate from the fetus.

    Conclusions:

    • Fetal-derived BTG and PF4 are present in amniotic fluid.
    • These markers do not appear to directly reflect fetal lung maturity based on current parameters.
    • Further research is needed to elucidate the role of fetal platelets and PAF in pregnancy.